JOURNAL OF CLINICAL SURGERY ›› 2026, Vol. 34 ›› Issue (7): 729-732.doi: 10.3969/j.issn.1005-6483.20260399

Previous Articles     Next Articles

The current situation and prospects of nanoknife therapy for locally advanced pancreatic cancer

TANG Xinyu, LIU Xiaolong, HONG Defei   

  1. Department of General Surgery, Sir Run Run Shaw Hospital, the Medicine School of Zhejiang University, Hangzhou 310016, China
  • Received:2026-05-06 Online:2026-07-20 Published:2026-07-20

Abstract: Pancreatic cancer is insidious in onset, highly aggressive, and associated with an extremely poor prognosis.Currently, surgical resection remains the primary means of prolonging survival in patients with pancreatic cancer; however, the majority of patients lose the opportunity for surgery at the time of diagnosis.Irreversible electroporation (IRE) is a non-thermal ablation technique that not only achieves local tumor ablation but also reverses the highly immunosuppressive tumor microenvironment.The combination of IRE with chemotherapy and immunotherapy is expected to yield improved clinical outcomes.This paper systematically reviews the latest clinical evidence on IRE combined with chemotherapy and immunotherapy, with a focus on the potential mechanisms by which IRE remodels the immunosuppressive microenvironment of pancreatic cancer.It also explores future directions for optimizing combination treatment strategies, aiming to provide new perspectives and a theoretical foundation for the treatment of pancreatic cancer.

Key words: irreversible electroporation, nanoknife, pancreatic cancer, chemotherapy, immunotherapy

[1] YANG Chong, YOU Xinyu, ZHANG Yu. Application experience and future perspectives of intestinal autotransplantation in radical resection for locally advanced pancreatic cancer [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(7): 737-740.
[2] MIAO Wenteng, FU Deliang. The role and feasibility of arterial resection and reconstruction in the surgical treatment of pancreatic cancer [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(7): 741-745.
[3] GUO Shiwei. Precision therapy for pancreatic cancer: current status and future directions: from A to AI [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(7): 746-751.
[4] HE Shaolong,ZHENG Chunlei,NING Kepeng. Feasibility analysis of immediate intraperitoneal hyperthermicperfusionchemotherapy after laparoscopic radical surgery for sigmoid colon cancer [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(6): 662-665.
[5] ZHANG Peng, ZHANG Qiang, LI Xiaoli, LIU Yun. Expression and clinical significance of serum microRNA-451,microRNA-15a,microRNA-133b in patients with pancreatic cancer [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(5): 534-538.
[6] HOU Wen, YU Hongxia, PAN Yuting, DUAN Jiali, YUN Hong. Efficacy analysis of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in young patients with peritoneal metastasis of colorectal cancer [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(5): 550-555.
[7] LI Jiangang,WU Shixing,XU Xinjian,LIU Chao. Construction of 1-year prognosis model of resectable pancreatic cancer based on gene expression and pathological features [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(3): 306-310.
[8] . Advances in perioperative therapy for non-small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(9): 933-937.
[9] . Hot topics and research advances in perioperative immunotherapy for non-small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(9): 938-942.
[10] . Opportunities and challenges of neoadjuvant immunotherapy innon-small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(9): 943-947.
[11] PAN Qing, NIU Yicong, CHEN Cheng, MA Dachang, WU Jun. Prediction model establishment for complete resolution of sentinel lymph node metastasis after neoadjuvant chemotherapy in breast cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(8): 846-851.
[12] SUN Yan, WANG Zheng, LIU Quanda. Hepatic arterial infusion chemotherapy for colorectal liver metastasis [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(8): 887-889.
[13] NIE Lei, ZHANG Haiyan, SHEN Jian, WU Dongde. Research progress in targeted and immunotherapy for biliary tract cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(7): 775-.
[14] YUAN Hao, TENG Jingyan, ZHANG Qiang. Research progress of immunotherapy in neoadjuvant therapy of esophageal cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(2): 210-212.
[15] . Clinical strategies and progress of whole-course nutritional management for pancreatic cancer patients [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(12): 1250-1254.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!